Patent US2579237A successfully refreshed from Google Patents.
Patent US4469795A successfully refreshed from Google Patents.
US4469795A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Radioassay for monosialoglycosphingolipid (GM1) ganglioside concentration
Assignee: Individual
•
Filing: 1981-08-26
•
Granted: 1984-09-04
•
Expires: 2001-08-26
Abstract
Abstract A radioassay test for the rapid and sensitive determination of the concentration of monosialoglycosphingolipid G M1 ganglioside concentrations in small volumes of cerebrospinal fluid from individual patients is based on the high affinity interaction between cholera enterotoxin and G M1 ganglioside. The level of G M1 ganglioside present in the cerebrospinal fluid has been shown to be an indicator of active central nervous system pathology. In the present invention, the use of highly specific toxins eliminates cross reactivity with the other gangliosides, thereby eliminating the need to process the cerebrospinal sample prior to assay, except for centrifugation. Results of a specific application of the subject radioassay to newborn infants and older infants and children (some of the latter having active neurologic disease) indicated that the G M1 ganglioside concentration in the cerebrospinal fluid is probably a function of both central nervous system tissue ganglioside content and turnover.
Inventors
- 👤 Edward Ginns
- 👤 Joseph French
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 10:47
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N33/60
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
147 words
A method of conducting a radioassay for G M1 ganglioside concentration in cerebrospinal fluid utilizing the high affinity interaction between cholera enterotoxin and G M1 ganglioside comprising the steps of preparing a radioiodinated cholera toxin solution, preparing liver membranes from a 0.25 M sucrose homogenate, preparing several quantities of known G M1 ganglioside concentration in solution, obtaining a count of 125 iodine cholera toxin bound to liver membranes by means of radioassay of various mixtures of said iodotoxin solution, liver membranes and respective G M1 ganglioside solutions, preparing a standard curve showing the variation in inhibition of cholera toxin binding to liver membranes for different mixtures of G M1 ganglioside concentrations, repeating the above steps on a solution of unknown G M1 ganglioside concentrations and comparing the results of said repeated steps with said standard curve to determine the amount of said unknown G M1 ganglioside concentration.
Claim 2
Independent Claim
147 words
A method of conducting a radioassay for G M1 ganglioside concentration in cerebrospinal fluid utilizing the high affinity interaction between cholera enterotoxin and G M1 ganglioside comprising the steps of preparing a radioiodinated cholera toxin solution, preparing liver membranes from a 0.25 M sucrose homogenate, preparing several quantities of known G M1 ganglioside concentration in solution, obtaining a count of 125 iodine cholera toxin bound to liver membranes by means of radioassay of various mixtures of said iodotoxin solution, liver membranes and respective G M1 ganglioside solutions, preparing a standard curve showing the variation in inhibition of cholera toxin binding to liver membranes for different mixtures of G M1 ganglioside concentrations, repeating the above steps on a solution of unknown G M1 ganglioside concentrations and comparing the results of said repeated steps with said standard curve to determine the amount of said unknown G M1 ganglioside concentration.
Claim 3
Dependent Claim
15 words
The method of claim 1 whereas said cholera enterotoxin is subunit B of cholera enterotoxin.
Claim 4
Dependent Claim
119 words
The method of claim 1 where said step of preparing a radioiodinated cholera toxin solution includes the sub-steps of: (a) dissolving one milligram of cholera toxin in 0.25-1.0 milliliters of buffer; (b) chromatographing said solution of buffered cholera toxin on a 10-50 milliliter column; (c) combining 10-100 micrograms of the foregoing solution with 0.5-5 millicuries of sodium 125 iodide; (d) adding 20-50 micrograms of chloramine T to form a reaction solution; (e) terminating the reaction after 30-120 seconds by the addition of 50-100 micrograms of sodium metabisulfite; (f) adding 100-500 microliters of 0.1 molar sodium phosphate buffer and 0.1-1% bovine serum albumin to the reaction solution; (g) eluting the iodonated cholera toxin; and (h) diluting the iodonated cholera toxin.
Claim 5
Dependent Claim
16 words
The method of claim 3 wherein said cholera toxin is subunit B of said cholera toxin.
Claim 6
Dependent Claim
27 words
The method of claim 3 wherein step (a) is immediately followed by the additional step of: (b) equilibrating said column with 100-250 millimolar sodium phosphate buffer pH7.3-7.5.
Claim 7
Dependent Claim
153 words
The method of claim 1 wherein said step of preparing liver membranes from a 0.25 M sucrose homogenate includes the sub-steps of: (a) centrifuging and decanting said liver membranes to form a supernatant; (b) recentrifuging and decanting said supernatant; (c) adding sodium chloride and magnesium sulphate to said supernatant to yield 100 millimolar sodium chloride and 200 micromolar magnesium sulphate; (d) centrifuging and decanting said solution to form a pellet; (e) suspending said pellet in 100-200 ml of 100 millimolar sodium phosphate buffer, centrifuging and decanting same to form a resedimented pellet; (f) suspending said resedimenteed pellet in a buffer solution and recentrifuging three times to form a final pellet; (g) suspending said final pellet in a 100 millimolar sodium phosphate buffer at a protein concentration of approximately 15 mg/ml; and (h) diluting said final pellet to a concentration of 1.5 mg/ml with 100 millimolar sodium phosphate buffer with 1% bovine serum albumin.
Claim 8
Dependent Claim
166 words
The method of claim 1 wherein said step of preparing several quantities of known G M1 ganglioside concentration includes the sub-steps of: (a) dissolving 500-1000 milligrams of bovine brain gangliosides in 20-30 milliliters of 100-200 millimolar sodium acetate buffer to form a solution; (b) adding one-third unit of neuraminidase enzyme and incubating the reaction solution at 37° C. for 36 hours; (c) adding one-third unit of neuraminidase enzyme to said reaction solution at 12 and 24 hours; (d) halting the reaction solution at approximately 72 hours by washing the solution with five volumes of 2:1 chloroform-methanol, thereby producing an upper phase and a lower phase, said upper phase containing said ganglioside; (e) washing said lower phase with a theoretical upper phase solution equivalent to said upper phase but free of said ganglioside, and combining said upper phases; (f) heating said methanol-containing upper phases at 40°-50° C. under vacuum to remove said methanol, and (g) dialyzing the remaining ganglioside-containing solution against distilled water for approximately 24 hours.
Claim 9
Dependent Claim
160 words
The method of claim 1 wherein the step of obtaining a 125 iodine count by means of radioassay of the mixture of radioiodinated toxin, liver membrane, and G M1 ganglioside solution includes: (a) adding G M1 ganglioside to a suitable receiving tube; (b) adjusting the volume of the solution to 100-200 μl by means of 0.1 M sodium phosphate buffer (pH 7.4) containing 1% (w/v) BSA; (c) adding 50 μl of 125 iodinated cholera toxin in 0.1 M sodium phosphate buffer (pH 7.4) with 1% (w/v) BSA; (d) mixing the mixture for 2-3 seconds; (e) incubating the mixture at 4-23° C. for 40-60 minutes; (f) adding 50 μl of liver membrane suspension; (g) continuing incubation of 4°-23° C. for 10-20 minutes with intermittent shaking of the mixture; (h) adding 2 ml of deionized-distilled water; (i) filtering the mixture; (j) washing the mixture twice with 5-10 ml deionized-distilled water; and (k) counting the radioactivity of the mixture with a gamma counter.
References Cited (Backward Citations)
US4125492A
Cited
US4225487A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-09-04 | 1988-03-05 | 1988-09-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-09-04 | 1992-03-05 | 1992-09-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-09-04 | 1996-03-05 | 1996-09-04 | $7700.00 | Window Closed / Lapsed |